LEXICON PHARMACEUTICALS INC (LXRX)
US5288723027 - Common Stock
| 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | 2019 (2019-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES | ||||||||
| Net Income | -177.12M | -101.90M | -87.80M | -58.60M | 130.10M | |||
| Depreciation Amortization | 554.00K | 400.00K | 300.00K | 2.90M | 3.70M | |||
| Income Taxes - Deferred | N/A | N/A | 0.00 | 0.00 | -6.00M | |||
| Change In Working Capital | 2.66M | 400.00K | -10.20M | 31.10M | -58.30M | |||
| Interest Paid | 10.06M | 2.30M | 800.00K | 17.40M | 19.20M | |||
| Other non cash items | 12.01M | 12.30M | 10.70M | -118.40M | 44.30M | |||
| OPERATING CASH FLOW | -161.90M | -88.90M | -87.00M | -143.00M | 113.80M | |||
| CASH FLOWS FROM INVESTING ACTIVITIES | ||||||||
| Capital Expenditure | -470.00K | -1.30M | -1.20M | -100.00K | -100.00K | |||
| Other Investing Activity | -49.47M | -69.80M | 3.30M | 380.80M | -155.80M | |||
| INVESTING CASH FLOW | -49.94M | -71.10M | 2.10M | 380.80M | -155.90M | |||
| CASH FLOWS FROM FINANCING ACTIVITIES | ||||||||
| Debt Issued/Reduced | 49.96M | 48.90M | -11.70M | -216.60M | -1.30M | |||
| Stock Issued/Repurchased | 138.00M | 93.30M | 34.40M | 68.90M | -900.00K | |||
| Other Financing Activity | N/A | N/A | N/A | N/A | N/A | |||
| FINANCING CASH FLOW | 187.96M | 142.20M | 22.70M | -147.60M | -2.20M | |||
| CHANGE IN CASH | -23.88M | -17.80M | -62.20M | 90.20M | -44.30M | |||
| FREE CASH FLOW | ||||||||
| Operating Cash Flow | -161.90M | -88.90M | -87.00M | -143.00M | 113.80M | |||
| Capital Expenditure | -470.00K | -1.30M | -1.20M | -100.00K | -100.00K | |||
| FREE CASH FLOW | -162.37M | -90.20M | -88.20M | -143.10M | 113.70M | |||
All data in USD